The impact of sarcopenia on short-term efficacy, toxic and adverse reactions, and prognosis in patients with non-small cell lung cancer undergoing concurrent chemoradiotherapy.

Front Nutr · 2026 · PMC13407192 · PMID 42523675

Europe PMC DOI

hedged sentence

0.0550

closest p · 1.1× alpha

0.0550

boldest claim

The sentences

a decreasing trendP = 0.055so close (0.05 < p ≤ 0.1)

80.0%, χ 2 = 5.371, P = 0.020), and the complete response rate (CR) showed a decreasing trend (4.3 vs. 20.0%, P = 0.055).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.